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Abstract The entire sequences of the type A nontoxic-non- 
hemagglutinin gene and an adjacent open reading frame desig- 
nated as orf22-a, which are located between the nenrotoxin and 
the HA-35 genes were determined. SDS-PAGE and N-terminal 
amino acid sequence analyses of the purified type A progenitor 
toxins (12S, 16S and 19S) indicate that the nontoxic-nonhemag- 
glutinins of 16S and 19S are single peptides of approximately 
120k, but that of 12S has a cleavage at the site between Pro-144 
and Phe-145 of this protein. 
l~,'y words." Clostridium botulinum; Botulinum toxin; 
N~urotoxin; Progenitor toxin; Nontoxic-nonhemagglutinin; 
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1. Introduction 
Toxigenic strains of Clostridium botulinum produce one or 
nore  of the seven immunologically distinct neurotoxins (type 
A-to-G). The neurotoxins, approximately 150 kDa proteins, 
e~ist in the bacterial cultures as stable, large complexes desig- 
nLted as progenitor toxins, which are found in three forms: 12S 
t~, xin (M,-  300k), 16S toxin (M r- 500k), and 19S toxin (Mr- 900k). 
21:pe A progenitor toxin involves three forms, 19S, 16S, and 
12S. Type B, C, and D involve two forms, 16S and 12S. Type 
E F, and G involve a single form, 12S, and 16S, respectively. 
I'~S and 16S toxins have hemagglutinin (HA) activity, but 12S 
t~xin does not. It was postulated that the 12S toxin is formed 
b,, association of a neurotoxin with a nontoxic component 
(~fr~120k) having no HA activity which is designated here 
a, nontoxic-nonHA. Whereas, the 16S and 19S toxins are 
f irmed by conjugation of the 12S toxins with HAs. In this study 
.~ show the SDS-PAGE profiles and N-terminal amino acid 
sequences of purified type A HA-positive (16S and 19S) and 
I-t A-negative (12S) progenitor toxins in addition to the com- 
pete gene sequences of type A nontoxic-nonHA gene and adja- 
c~ nt open reading frame (orf22-a), and the results of compar- 
alive analyses of these amino acid sequences with those of other 
t?.pes of C. botulinum progenitor toxins. 
2. Materials and methods 
2 1. Purification of progenitor toxins 
The HA-positive (19S and 16S) and HA-negative (12S) progenitor 
t, xins were purified from the culture fluid of C. botulinum type A strain, 
*Corresponding author. Fax: (81) (86) 222-1815. 
A-NIH. The organisms were cultured by a cellophane tube procedure 
[1], and the culture medium was centrifuged (6000 x g, 30 min). The 
supernatant was precipitated with 60% saturated ammonium sulfate. 
After removing RNA in the precipitate by protamine treatment [2], this 
preparation was subjected to a SP-Toyopearl 650M (Tosoh, Tokyo, 
Japan) column equilibrated with 50 mM sodium acetate buffer (pH 
4.2). The column was washed with 100 ml of this solution, and the 
concentration f NaC1 was then increased linearly to 0.5 M. The frac- 
tions which showed both toxic and hemagglutinating activity, and the 
fraction which showed only toxic activity were collected separately, 
concentrated by70% saturation of ammonium sulfate, and then sub- 
jected to a Sephacryl S-300 (Pharmacia Biotechnology AB, Uppsala, 
Sweden) column equilibrated with 50 mM sodium acetate buffer (pH 
4.2) containing 0.5 M NaC1, to obtain purified HA-positive (16S and 
19S) and HA-negative (12S) progenitor toxins. 
2.2. SDS-PAGE and N-terminal mino acid sequencing 
SDS-PAGE and N-terminal amino acid sequencing analyses were 
performed as described previously [3]. 
2.3. Preparation of DNA and PCR amplification 
Total DNA was isolated from A-NIH strain as described previously 
[4]. PCR amplification was performed in a 50 pl reaction mixture 
containing 200 ng of template DNA, 100 nM of each primer, 1 x Ex 
Taq buffer (Takara Shuzo Co. Ltd., Kyoto, Japan), 200 pM of each 
dNTP, and 1.25 unit of Takara Ex Taq DNA polymerase (Takara 
Shuzo Co. Ltd.), by using a GeneAmp PCR System (Model 9600-R; 
Perkin-Elmer, Foster City, CA, USA). The PCR profile was 27 cycles 
of 94°C for 30 s, 53°C for 30 s, and 72°C for 180 s. 
2.4. Cloning and nucleotide s quencing 
PCR products were cloned irectly into pT7 Blue T-vector (Novagen, 
Madison, WI, USA) according to the manufacturer's in tructions and 
nested eletion of the cloned inserts was constructed bypartial unidirec- 
tional hydrolysis by using a Deletion kit (Takara Shuzo Co. Ltd.). The 
sequence was determined with an automated model 373A DNA se- 
quencer and the PRISM sequencing kit (Perkin-Elmer) as outlined in 
the manufacturer's in tructions. The sequence was determined on two 
cloned fragments derived from different PCR experiments. Where the 
two clones differed in sequence, a third, independently amplified frag- 
ment was cloned and sequenced. Sequence data were analysed with the 
GENETYX-MAC sequence analysis oftware (version 7.3; Software 
Development Co. Ltd., Tokyo, Japan). 
2.5. Nucleotide s quence accession number 
The GSDB/DDBJ/EMBL/NCBI accession umber for the nucleo- 
tide sequence reported in this paper is D67030. 
3. Results and discussion 
3.1. SDS-PA GE and N-terminal amino acid sequence analyses 
of progenitor toxins 
HA-positive and HA-negative progenitor toxins were puri- 
fied as described in section 2. As reported previously [2], the 
HA-positive progenitor toxin preparation is a mixture of 16S 
and 19S toxins and HA-negative progenitor toxin preparation 
is 12S toxin. These preparations were subjected to SDS-PAGE 
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Fig. 1. SDS-PAGE of HA positive (lane 1) and HA-negative (lane 2) 
progenitor toxin fractions eparated on Sephacryl S-300. Each toxin 
fraction (10pg) was heated at 100°C for 7 min in the presence of 2-ME 
and subjected to SDS-PAGE (5-15% acrylamide gradient gel). The gel 
was stained with CBB R-250. The positions of nontoxic-nonHA (120k), 
106k component of 12S toxin, heavy chain (93k) and light chain (55k) 
of neurotoxin, HA-52 (52k), HA-35 (35k), HA-19 (19k), HA-15 (15k), 
and 13k component of 12S toxin are indicated by arrows. M = molec- 
ular weight standards, broad range (Bio-Rad). 
with a reducing agent (Fig. 1). HA-positive progenitor toxins 
demonstrated seven major bands with Mrs of approximately 
120k, 93k, 55k, 52k, 35k, 19k, and 15k. Based on previous 
reports [3,5 7,9], it can be concluded that the band of 120k is 
nontoxic-nonHA, and those of 93k and 55k are the heavy and 
light chains of the neurotoxin, respectively, and the remaining 
bands are the subcomponents of HA. On the contrary, the 
HA-negative progenitor toxin showed two bands with Mr of 
106k and 13k in addition to the heavy and light chains of 
neurotoxin, indicating that the nontoxic-nonHA of 12S toxin 
consists of two fragments. In an attempt o confirm this hy- 
pothesis, the N-terminal amino acid sequences of these non- 
toxic components were determined by a direct protein microse- 
quencing procedure (Table 1). The N-terminal amino acid se- 
quences of nontoxic-nonHA, HA-52, and HA-15 were highly 
homologous to those of type C (64-82% identity), whereas the 
sequences of HA-35 and HA-19 showed only 3040% identity 
to those of type C [3,6,8]. These N-terminal sequences are 
consistent with those of type A HA subcomponents reported 
by Somer and DasGupta [9]. 
PCR (--,4.8 kb) 
I 
pAHR3.-* ,.- pAR3 
aha-35 or/ 22-a ant at)( 
Fig. 2. Diagrammatic representation fnontoxic-nonHA gene and its 
surrounding region showing position of primers used in PCR for clon- 
ing. The respective genes coding for neurotoxin (atx), nontoxic-nonHA 
(ant), HA-35 (aha-35), and orf22-a are shown by open boxes driving 
their directions of transcription. The sequences of primers were as 
follows: pAHR3 5"-ATCATTTAATGAATTTTGTATTAC-3' ; pAR3 
5'-ATATCAACACCATTTACAGG-3'. 
3.2. Sequence determination of nontoxic-nonHA gene and orf 
22-a 
From the reported construction of the type C and D 16S 
progenitor toxin gene clusters [3,6-8,10], we deduced that also 
in type A the nontoxic-nonHA gene is located between the 
HA-35 gene and the neurotoxin gene. Therefore, to amplify the 
nontoxic-nonHA gene (ant) we designated PCR primers 
pAHR3 and pAR3, corresponding to the coding regions for 
N-terminals of the HA-35 gene (aha-35) and the neurotoxin 
gene (atx), respectively (Fig. 2). The pAHR3 was designed with 
the N-terminal protein sequence data of HA-35. Nucleotides in 
the positions of codon degeneracy were chosen on the basis of 
those most commonly found in clostridial genes [11]. pAR3 was 
designed with the nucleotide sequence of the 5'-end of the type 
A neurotoxin gene [12,13]. The PCR products (about 4.6 kb) 
were cloned and sequenced as described in section 2. The com- 
plete nucleotide sequences of the ant and the adjacent region 
are shown in Fig. 3. The gene encodes a protein of 1193 amino 
acids with a calculated M r of 138.1 kDa. The ant ends 46 
nucleotides before the start of atx. Upstream of the ant, there 
exists an open reading frame (orf22-a) coding for 178 amino 
acids with a calculated M r of 21.7 kDa. The amino acid se- 
quence ncoded here shows 52.2% identity to that of the orf-22 
of type C [8]. The N-terminal amino acids of the nontoxic- 
nonHAs of the HA-positive progenitor toxins determined by 
protein sequencing were located within the open reading frame 
starting at Met-l, and the those of the 13k and 106k compo- 
nents of the HA-negative progenitor toxin were located within 
the open reading frame starting at Met-1 and Phe-145, respec- 
tively. These results indicate that the nontoxic-nonHA of 12S 
toxin have a nick at the site between Pro-144 and Phe-145. 
Deduced 13k and 106k components consists of 144 and 1049 
amino acids, and is calculated to be 15.9 kDa and 122.2 kDa, 
Table 1 
N-Terminal amino acid sequences of nontoxic omponents 







HA-negative progenitor toxin 
106 k component 
13 k component 
FPYAGYRETNY 
MNINDNLS INXPV 
X = not determined. 
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ataacatataacataatcaaattattttttgtaaacctaaaatttaaatatatcaaatt  60 
-~tattagtatgtttacataattgattatggatatttcgtaaaaatggcttattaaaaat 120 
-~aaaggcaattagtttatttatagtataataaaaaaataatatgtatattatggaaqgg 180 
aqtqqtaaatatgaataaattgtt t t tacaaattaaaatgttaaaaaatgacaataggg 240 
SD M N K L F L Q I K M L K N D N R  16 
or f22-a~ 
~tttcaagaaatttttaagcattttgaaaaaactataaatatatttactagaaaatata 300 
F Q E I F K H F E K T I N I F T R K Y  36 
tatatatgataattacaatgatattttgtaccatttatggtatacacttaaaaaagttg 360 
' I Y D N Y N D I L Y H L W Y T L K K V  56 
tttgagcaatttcaatacacaaaatgatttagaqagatatattagtaggactttaaaaa 420 
, L S N F N T Q N D L E R Y I S R T L K  76 
atattgcttagatatttgcaataaaagaaagattgataaqaaaataatatataattcag 480 
Y C L D I C N K R K I D K K I I Y N S  96 
aattgtagataagaaattaagcttaatagcaaatagttattcaagttatttagaatttg 540 
, I V D K K L S L I A N S Y S S Y L E F  116 
atttaatgatttaatatccatattacctgatgatcaaaagaaaattatatatatgaaat 600 
, F N D L I S I L P D D Q K K I I Y M K  136 
tgttgaaqatattaaggagatagatatagctaaaaaacttaatataagtcgtcaatctg 660 
" V E D I K E I D I A K K L N I S R Q S  156 
atataaaaataaaataatggctttagagagattagaacccatattgaaaaaattaatta 720 
I Y K N K I M A L E R L E P I L K K L I  176 
tatgtagtttatatttttaaaaaattttaggtttacaaaaaatagtgtggctatgttat  780 
tataaatgataagaatatactgaaaaatgtatccaaaatttaagggggcgtgtatagta 840 
ataattaaaagtatgtgcgttgaaataaatttaggags_q~_qgttagatatgaatataaa 900 
SD M N I N  4 
gacaacttaagtataaattccccqgtagataataaaaatgttgtagtagttagagctag 960 
D N L S I N S P V D N K N V V V V R A R  24 
aaaactgatacggtttttaaggcttttaaggttgctcccaatatttgggtggcgccaga 1020 
K T D T V F K A F K V A P N I W V A P E  44 
aqatattatggcgaatctttgagtatagatgaagaatataaagttgatgggggaatata 1080 
R Y Y G E S L S I D E E Y K V D G G I Y  64 
9attctaattttctttcacaagatagtgaaaaagataagttcttacaagccattattac 1140 
D S N F L S Q D S E K D K F L Q A I I T  84 
ttgttaaaaagaattaatagtactaacgctggggaaaagttattatctttgatttctac 1200 
L L K R I N S T N A G E K L L S L I S T  104 
a ctattccatttccttatggatatataggtggagggtattatgcacctaatatgattac 1260 
A I P F P Y G Y I G G G Y Y A P N M I T 124 
t ttggatcagcaccaaaatctaataaaaaattgaattctt  taatttcaagtactattcc 1320 
F G S A P K S N K K L N S L I S S T I P 144 
a t tcct tatgcaggatatagagaaacaaattatctttcatctgaagataataaaagt t t 1380 
F_ p Y A G Y R E T N Y L S S E D N K S F 164 
c atqcatctaatatagttatttttggtccaggagcaaacatagtagaaaacaatactgt 1440 
Y A S N I V ~ F G P G A N I V E N N T V 184 
t tttataaaaaggaagatgcagaaaatggaatgggaacaatqactgaaatatggttcca 1500 
F Y K K E D A E N G M G T M T E I W F Q 204 
a catttctaacct at aaatatgacgaatt tt atat tgatcct gcaatagaat taat aaa 1560 
P F L T Y K Y D E F Y I D P A I E L I K 224 
a gtttaataaaatctct ttatt tct tatatqgtat aaaacctagtgatgatttagt tat 1620 
C L I K S L Y F L Y G I K P S D D L V I 244 
t catat aqatt aagaagtgaat tagagaatatagaat actcacaattgaatatagttga 1680 
P Y R L R S E L E N I E Y S Q L N I V D 264 
t tactagtatctggaggcattgatcctaaatttataaatacagatccatattqgtttac 1740 
L L V S G G ~ D P K F I N T D P Y W F T 284 
a ataat tatttctcaaatgcaaaaaaagt gtt t gaagatcat aggaat at ttatgaaac 1800 
D N Y F S N A K K V F E D H R N I Y E T 304 
a aaat tgaaggaaataatgccat tggt aat gatat aaaattgagattaaaacaaaagt t 1860 
E I E G N N A I G N D I K L R L K Q K F 324 
t ~aatcaatatcaatgatatatgggaattaaatttaaattatttctctaaagagtttag 1920 
R I N I N D I W E L N L N Y F S K E F S 344 
c ttatgatgccagatagatttaataatgcacttaaacatttttatagaaaacaatacta 1980 
I M M P D R F N N A L K H F Y R K Q Y Y 364 
c aaatagattatccagaaaattatagt ataaatggtt tt gt taatggtcaaat taat gc 2040 
K I D Y P E N Y S I N G F V N G Q I N A 384 
t aat tatcttt at cagatagaaatcaagatattataaat aaacct gaagaaat aattaa 2100 
Q L S L S D R N Q D I I N K P E E I I N 404 
t tattaaatggaaataatgtttcat taatgagaagtaat attt at ggtgatggat taaa 2160 
L L N G N N V S L M R S N I Y G D G L K 424 
a gcact gtagat gat t ttt acagt aat tat aaaatcccatataat agagcctatgaata 2220 
S T V D D F Y S N Y K I P Y N R A Y E Y 444 
t art ttaataat tcaaatgattct tct ttagataatgt t aacattggagtaat agacaa 2280 
H F N N S N D S S L D N V N I G V I D N 464 
t ttccagagattatagatgtaaatccttataaqgaaaattgtgataagttttcaccggt 2340 
I P E I I D V N P Y K E N C D K F S P V 484 
a agaaaattacaagtactagagaaatt aat acaaatataccatggcctataaatt at t t 2400 
Q K I T S T R E I N T N I P W P I N Y L 504 
a aagct caaaat actaacaatgaaaaatt tagt t tatcctcagat tttgtagaagtagt 2460 
Q A Q N T N N E K F S L S S D F V E V V 524 
ttcttctaaagataaatctttagtgtattctttcttatctaatgtaatgttttatttaga 2520 
S S K D K S L V Y S F L S N V M F Y L D 544 
tt ccataaaggat aatagtcctattgatacagataaaaaatat t atttatggt taagaga 2580 
S I K D N S P I D T D K K Y Y L W L R E 564 
qattt ttagaaattattcttttgatatt act gcaactcaagaaattaat actaattgtgg 2640 
I F R N Y S F D I T A T Q E I N T N C G 584 
tattaat aaagtagtaacttggt ttgggaaagcat taaatattt taaatacat ctgat tc 2700 
I N K V V T W F G K A L N I L N T S D S 604 
ttttgtagaagaatttcaaaatttaggggcaatttcacttattaataaaaaagaaaattt 2760 
F V E E F Q N L G A I S L I N K K E N L 624 
aagtatgccaataattgagagt tat gaaat ccctaacgatatgt taggattaccactaaa 2820 
S M P I I E S Y E I P N D M L G L P L N 644 
tgat t taaatgaaaaat tat t taacatatat tot aaaaacacagct tattt taaaaaaat 2880 
D L N E K L F N I Y S K N T A Y F K K I 664 
ctactataatttcctagatcagtggtggacacaatattatagtcaatattttqatttaat 2940 
Y Y N F L D Q W w T Q Y Y S Q Y F D L I 684 
ttgtat 9gctaaaagatcagtgt tagct caagaaact t taataaaaagaataat acaaaa 3000 
C M A K R S V L A Q E T L I K R I I Q K 704 
aaaat tgagt tat ttaat aggaaatt ctaatatatcatctgataact t agcat tgatgaa 3060 
K L S Y L I G N S N I S S D N L A L M N 724 
tcttacaacaacaaatacattaagagatatttcaaacgaatcacaaatagcaatgaataa 3120 
L T T T N T L R D I S N E S Q I A M N N 744 
tgtagatagttttttaaataatgccqctatatgtgtttttgaaagtaatatatatcctaa 3180 
V D S F L N N A A I C V F E S N I Y P K 764 
at ttat t tct tttatggaacaatgtattaat aatat aaatat taagacaaaagaatttat 3240 
F I S F M E Q C I N N I N I K T K E F I 784 
acaaaaatgt act aatat taatgaagat gaaaaattacaattaat t aaccagaatgtt t t 3300 
Q K C T N I N E D E K L Q L I N Q N V F 804 
taatagcttagattttgaattcttaaatattcaaaatatgaaaagtttatttagttcaga 3360 
N S L D F E F L N I O N M K S L F S S E 824 
gacagcattacttataaaggaaqaaacttggccttatgaactagtgttatatqcttttaa 3420 
T A L L I K E E T W P Y E L V L Y A F K 844 
ggaaccaggtaataatgttatcggagatgcatctggtaaaaatacatcaatagaatattc 3480 
E P G N N V I G D A S G K N T S I E Y S 864 
taaggacat aggtttagt tt atggaataaat agtgatgcattatat t t aaatggat ct aa 3940 
K D I G L V Y G I N S D A L Y L N G S N 884 
tcaaagtataagtt ttt ctaatgatttct t t gagaatggat taact aacagt t ttt caat 3600 
Q S I S F S N D F F E N G L T N S F S I 904 
t tart t t tggttgagaaat t t gggcaaagatact at taaatctaagtt aatagqtagt aa 3660 
Y F W L R N L G K D T I K S K L I G S K 924 
ggaagataat tgt ggttgggaaattt at tttcaagatactgggttggt t<tcaatat gat 3720 
E D N C G W E I Y F Q D T G L V F N M I 944 
agattctaatggaaatgagaagaatatatatctatctgatgtttctaataatagttggca 3780 
D S N G N E K N I Y L S D V S N N S W H  964 
ctatataactatatctgtagatcqtttaaaagaacaattattaatatttattgatgataa 3840 
Y I T I S V D R L K E Q L L I F I D D N  964 
tttagtggctaatgaaagtattaaggaaattttaaatatctattcaagtaatataatttc 3900 
L V A N E S I K E I L N I Y S S N I I S  1004 
tttattaagcgagaataatccaagttatattgagggattaactattttaaataaacccac 3960 
L L S E N N P S Y I E G L T I L N K P T  1024 
tacaagtcaggaagttttgagtaattattttgaagttctaaataattcatatataagaga 4020 
T S Q E V L S N Y F E V L N N S Y I R D  1044 
cagtaatgaagaacgattagaatacaataagacatatcaattatataattatgtattttc 4080 
S N E E R L E Y N K T Y Q L Y N Y V F S  1064 
agataagcctatatgtgaagttaaacaaaataataatatatatttaacaattaataatac 4140 
D K P I C E V K O N N N I Y L T I N N T  1084 
aaacaatttaaatctacaagcttctaaatttaaattattaaqtataaatccaaataaaca 4200 
N N L N L Q A S K F K L L S I N P N K Q  1104 
atatgttcaaaaacttgatgaggtaataatttctgtattagataatatggaaaaatatat 4260 
Y V Q K L D E V I I S V L D N M E K Y I  1124 
agatatatctgaagataatagattgcaactaatagataacaaaaataacgcaaagaagat 4320 
D I S E D N R L Q L I D N K N N A K K M  1144 
gataattagtaatgatatat~tatttccaattgtttaaccctatcttataacggtaaata 4380 
I I S N D I F I S N C L T L S Y N G K Y  1164 
tatatgtttatctatgaaagatgaaaaccataattggatgatatgtaataatgatatgtc 4440 
I C L S M K D E N H N W M I C N N D M S  1184 
aaagtatttgtatttatggtcatttaaataattaataatttaattaattttaaatattat  4500 
K Y L Y L W S F K *  
aaqaqqtqt taaatatgccat t tg t taataaacaat t taat ta taaagatG~.~ 4560 
SD M P F V N K Q F N Y ~ D P V N  15 
. . .~S~ 457 0 
G V D  
F ',g. 3. Nucleotide sequence of nontoxic-nonHA gene (ant), orf22-a and surrounding region. The translated amino acid sequence is given under the 
second nucleotide of each codon. The position of the pAR3 primer is indicated by dotted underline. The putative Shine-Dalgarno (SD) regions 
ct~mplementary to the 3'-end of C. perfringens 168 rRNA [14] are underlined. The amino acid sequence corresponding to that determined by protein 
N-terminal analysis is underlined. Stop codons are indicated by asterisks. 
















i : ~ INDNLS INS P ~  D TVFKAFKVAPN IWVAPERYYGE S LS I DE EYKVD 60 
i : MD IND DLNINS PVDNKNVVlVRARKTN TFFKAFKVARNIWVAPE RYYGE PLD IAE EYKLD 60 
1 : MD IND DLN INS PVDNKNVVIVRARKTNTFFKAFKVAPN IWVAPE RYYGE PLD IAE EYKLD 60 
1 : MK INGNLN I D S PVDNKNVAIVRSRN - QMFFKAFQVAPN IW IVPE RYYGE S LK I NE DQKFD 59 






61 :GGIYDSNFLSQDSEKDKFLQAIITLI/q{INSTNAGEKLLSLISTAIPFPYGYIGGGYYAP 120 
61 :GGIYDSNFLSQDSERENFLQAI I I~NNTISGKQLLSL ISTA IPFPYGYIGGGYSSP 120 
61 :GGIYDSNFLSQDSERENFLQAI I ILLKRINNTISGKQLLSLISTA/PFPYGYIGGGYSSP 120 
60 : GGIYDSNFLSTNNEKDDFLQATIKLLQRINNNWGAKLLSL I  STAIPFPYENNT ... . . .  113 
61 : GGIYDENFLKENSE KEE FLQAI I L~NNN I I GQKLLSLMCTS I PFLHEYKQ ... . . .  114 
121 :NMITFGSAPKSNKKLNSLISSTIP~PYAGYRETNYLSSEDNKSFYASNIVIFGPGANIVE 180 
121 :N IFTFGKTPKSNKKLNSLV~TIPFPFGGYRETNYIESQNNKNFYASNI I IFGPGSNIVE 180 
121 : N I FT FGKTPKSNKKLNSLVT~T I PFPFGGYRETNYIESQNNKNFYASNIVI  FGPGSNIVE 180 
114 : . . . . . . . . . . . . . . . . . . . . . . . . . . .  EDYRQTNYLS SKNNEHYYTANLVIFGPGSNI K 146 
115 : . . . . . . . . . . . . . . . . . . . . . . . . . . .  GDYRQSNYLGSKNSEYLYSANIVIFGPGSNIVK 147 
Fig. 4. Amino acid alignment of the N-terminal regions of nontoxic-nonHA from type A, type C [7], type D [10], type E [15], and type F [16] strains. 
Identical amino acids in all, or all except one, of the sequences are shown in bold. The repeated motifs are underlined. The arrowheads indicate 
N-terminal amino acids of ~ 100k components of 12S toxins determined xperimentally b  protein sequencing. 
respectively, which are in good agreement with the 13 k and 106 
k estimated by SDS-PAGE. 
3.3. Comparison of type A nontoxie-nonHA with other 
nontoxic-nonHAs 
The amino acid identity and similarity values of type A non- 
toxic-nonHA with those of other types of C. botulinum progen- 
itor toxins published previously are shown in Table 2. The 
nontoxic-nonHA of type A shows 65.4%, 65.4%, 65.8%, and 
70.8% identity with nontoxic-nonHA of types C, D, E, and F. 
A multiple alignment of N-terminal regions of the nontoxic- 
nonHAs of types A, C, D, E, and F is shown in Fig. 4. As 
described above, the type A nontoxic-nonHAs of the 16S and 
19S toxins are single peptides, but that of 12S toxin has a 
cleavage. The same phenomena were observed in type D [10], 
and in type C (unpublished data). N-Terminal sequencing of 
the nontoxic-nonHA fragments of purified 12S and 16S of type 
A, C, and D toxins revealed that these processing occurs after 
the Pro- 144, Thr-140, and Thr- 140, respectively. These residues 
are contained in a region that includes a short repeat of the 
sequence, L-LIN-S-L-I/M/V-S/T-T/S-A/T-I-P-F-P/L-Y/F-G/ 
A, and the cleavage occur the second repeat. The nontoxic- 
nonHAs from type E and F strains, which produce only HA- 
negative progenitor toxins (12S), have a common deletion of 
the second repeat with respect o those from type A, C, and D 
strains, which produce both HA-positive and HA-negative pro- 
genitor toxins. These results indicate that the region in and 
around the second repeat motif may have a critical role in 
forming HA-positive progenitor toxins, probably by the bind- 
ing of the HA to the nontoxic-nonHA 
Table 2 
Percentage amino acid identities (lower left-hand triangle) and similar- 
ities (upper ight-hand triangle) of nontoxic-nonHA 
A C D E F 
A 94.1 94.0 89.6 90.7 
C 65.4 99.7 88.4 88.6 
D 65.4 99.6 88.7 88.9 
E 65.8 55.8 55.8 - 93.2 
F 70.8 58.2 58.0 71.1 
Acknowledgements." This work was supported in part by the Grant 
07670311 from the Ministry of Education of Japan. We thank Naomi 
Uchiage and Kiyomi Hamada for technical ssistance. We also thank 
Dr. Hiroyuki Ohmori, Department ofUrology, Okayama University 
Medical School, for his critical reading of this manuscript. 
References 
[1] Stern, M. and Wentzel, L.M. (1950) J. Immunol. 65, 175-183. 
[2] Sugii, S. and Sakaguchi, G. (1975) Infect. Immunol. 12, 1262 
1270 
[3] Fujinaga, Y., Inoue, K., Shimazaki, S., Tomochika, K., Tsuzuki, 
K., Fujii, N., Watanabe, T., Ohyama,T., Takeshi, K., Inoue, K. 
and Oguma, K. (1994) Biochem. Biophys. Res. Commun. 205, 
1291 1298. 
[4] Fujinaga, Y., Takeshi, K. Inoue, K., Fujita, R., Ohyama, T., 
Moriishi, K. and Oguma, K. (1995) Biochem. Biophys. Res. Com- 
mun. 213, 737~45. 
[5] DasGupta, B.R. and Sugiyama, H. (1972) Biochem. Biophys. Res. 
Commun. 48, 108 112. 
[6] Tsuzuki, K., Kimura, K., Fujii, N., Yokosawa, N., Indoh, T., 
Murakami, T. and Oguma, K. (1990) Infect. Immunol. 58, 3173- 
3177. 
[7] Tsuzuki, K., Kimura, K., Fujii, N., Yokosawa, N. and Oguma, K. 
(1992) Biochem. Biophys. Res. Commun. 183, 1273-1279. 
[8] Hauser, D., Eklund, M.W., Boquet, P. and Popoff, M.R. (1994) 
Mol. Gen. Genet, 243, 631-640. 
[9] Somers, E. and DasGupta, B.R. (1991) J. Protein Chem. 10, 415- 
425 
[10] Ohyama, T., Watanabe, T., Fujinaga,Y., Inoue, K., Sunagawa, 
H., Fujii, N., Inoue, K. and Oguma, K. (1995) Microbiol. Immu- 
nol. 39, 457~465. 
[11] Young, M., Minton, N.P. and Staudenbaouer, W. L. (1989) 
FEMS Microbiol. Rev. 63, 301-326. 
[12] Binz, T., Kurazono, H., Popoff, M.R., Eklund, M.W., Sakaguchi, 
G., Kozaki, S., Krieglstein, K., Henschen, A., Gill, D.M. and 
Niemann, H. (1990) J. Biol. Chem. 265, 9153-9158. 
[13] Thompson, D.E., Brehm, J.K., Oultram, J.D., Swinfield, T.J., 
Shone, C.C., Atkinson, T., Melling, J. and Minton, N.R (1990) 
Eur. J. Biochem. 189, 73 81. 
[14] Garnier, T., Canatd, B. and Cole, S.T. (1991) J. Bacteriol. 173, 
5431 5438. 
[15] Fujii, N., Kimura, K., Yokosawa, N., Yashiki, T., Tsuzuki, K. and 
Oguma, K. (1993) J. Gen. Microbiol. 139, 79-86. 
[16] East, A.K. and Collins, M.D. (1994) Curr. Microbiol. 29, 69- 
77. 
